Log in to save to my catalogue
Log in to save to my catalogue

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy

| Ask | Become a Library member

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5da78fe415b84b81b926cb80e82ca133

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy

About this item

Publication information

Publisher

England: BioMed Central Ltd

Subjects

More information

Scope and Contents

Contents

Gut microbiota-derived urolithins may influence multiple myeloma (MM) disease progression and treatment. We analyzed urolithins and their associated microbiota in a retrospective cohort of 45 patients with active MM or premalignant disease using mass spectrometry and 16S rRNA gene sequencing.
Patients with detectable levels of urolithin in serum...

Alternative Titles

Full title

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5da78fe415b84b81b926cb80e82ca133

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5da78fe415b84b81b926cb80e82ca133

Other Identifiers

ISSN

2049-2618

E-ISSN

2049-2618

DOI

10.1186/s40168-025-02045-6

How to access this item

Log in as a Library member

View record in Gale

About resource

View in old catalogue

Connecting people and collections